Risk factors for early mortality from lung cancer: evolution over the last 20 years in the French nationwide KBP cohorts.

ABSTRACT:

Background

The impact of the most recent advances, including targeted therapies and immune checkpoint inhibitors, on early (3-month) mortality in lung cancer is unknown. The aims of this study were to evaluate the real-world rate of and risk factors for early mortality, as well as trends in early mortality over the last 20 years.

Materials and methods

The KBP prospective observational multicenter studies have been conducted every 10 years since 2000. These studies collect data on all newly diagnosed patients with lung cancer (all stages and histologies) over 1 year in non-academic public hospital pulmonology or oncology units in France. In this study, we analyzed data on patient and tumor characteristics from participants in the KBP-2020 cohort and compared the characteristi

SUBMITTER: Hoang TCT 

PROVIDER: S-EPMC11214995 | biostudies-literature | 2024 Jun

REPOSITORIES: biostudies-literature